SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bäcklund, T.
Right arrow Articles by Laine, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bäcklund, T.
Right arrow Articles by Laine, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Activation of protective and damaging components of the cardiac renin-angiotensin system after myocardial infarction in experimental diabetes

Tom Bäcklund

Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

Päivi Lakkisto

Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland

Eeva Palojoki

Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, Department of Cardiology, Helsinki University Central Hospital, Helsinki, Finland

Tina Grönholm

Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

Antti Saraste

Department of Anatomy, University of Turku, Turku, Finland

Piet Finckenberg

Institute of Biomedicine, Pharmacology, University of Helsinki, Biomedicum Helsinki, Finland

Eero Mervaala

Institute of Biomedicine, Pharmacology, University of Helsinki, Biomedicum Helsinki, Finland

Ilkka Tikkanen

Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, ilkka.tikkanen{at}helsinki.fi, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

Mika Laine

Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, Department of Cardiology, Helsinki University Central Hospital, Helsinki, Finland

Introduction. Diabetes is associated with prolonged apoptotic cell death of cardiac myocytes and adverse remodelling after myocardial infarction (MI). Because the renin-angiotensin system (RAS) has a major role in the remodelling, we studied whether diabetes is associated with altered regulation of RAS after MI in rats.

Methods. Male Wistar rats were randomised to receive either streptozotocin (diabetic group) or citrate buffer (control group) intravenously. MI was produced four weeks later by ligating the left descending coronary artery.The rats were sacrificed 1, 4 and 12 weeks after the operation. Angiotensin-converting enzyme (ACE) and angiotensin-converting enzyme 2 (ACE 2), angiotensin type 1 and 2 receptors (AT1-receptor, AT2-receptor), and connective tissue growth factor (CTGF) mRNA expression were determined.

Results. The expression of both protective and damaging components of RAS increased after MI. However, myocardial ACE 2 and AT2-receptor messenger ribonucleic acid (mRNA) expression levels were significantly lower in diabetic compared to non-diabetic rats 1 week after MI. In contrast, AT1-receptor, ACE and CTGF mRNA levels were up-regulated in diabetic as compared with non-diabetic rats 12 weeks after MI.

Conclusion. The activation of the protective components of RAS (ACE 2 and AT2-receptor) was blunted early after MI in diabetic rats, whereas the levels of ACE, AT1-receptor and CTGF mRNA leading to adverse effects on myocardium, were elevated in diabetic as compared with non-diabetic rats.This unbalanced activation of the RAS may influence the pathophysiology of myocardial injury in diabetes after MI.

Key Words: renin-angiotensin system • myocardial infarction • diabetes

Journal of Renin-Angiotensin-Aldosterone System, Vol. 8, No. 2, 66-73 (2007)
DOI: 10.3317/jraas.2007.018
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement